Vertex Innovation Awards
The Vertex Innovation Awards fund innovative clinical research to improve care and outcomes for people with cystic fibrosis, with projects selected by an independent expert committee.
Funder: Vertex Pharmaceuticals
Due Dates (Anticipated): December 2026 (Vertex Innovation Awards application deadline, projected)
Funding Amounts: Up to $750,000 USD per project; up to four projects funded annually; funding is typically for one year.
Summary: Supports innovative and collaborative clinical research projects to improve care for people with cystic fibrosis, with selection by an independent expert committee.
Description
The Vertex Innovation Awards (VIA) are designed to support innovative, collaborative clinical research projects that advance the care of people with cystic fibrosis (CF). VIA is open to established researchers leading clinical research initiatives in CF. Each year, up to four projects are selected for significant funding, with proposals evaluated by an independent committee of experts outside of Vertex Pharmaceuticals. The program aims to foster research that can lead to meaningful improvements in CF patient outcomes and care.
